NRX Pharmaceuticals, Inc. (NRXP) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.34 | +43.2% |
| 2024 | $-2.36 | +40.7% |
| 2023 | $-3.98 | -563.3% |
| 2022 | $-0.60 | +69.7% |
| 2021 | $-1.98 | -31.1% |
| 2020 | $-1.51 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.34 | +43.2% |
| 2024 | $-2.36 | +40.7% |
| 2023 | $-3.98 | -563.3% |
| 2022 | $-0.60 | +69.7% |
| 2021 | $-1.98 | -31.1% |
| 2020 | $-1.51 | — |